These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

545 related items for PubMed ID: 17266397

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R, Koike T, Imai Y, Nomura-Furuwatari C, Takaoka K.
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S, Takahashi T, Kanno T, Ariyoshi W, Shinmyouzu K, Tujisawa T, Nishihara T.
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [Abstract] [Full Text] [Related]

  • 27. Osteoblast-derived TGF-beta1 stimulates IL-8 release through AP-1 and NF-kappaB in human cancer cells.
    Fong YC, Maa MC, Tsai FJ, Chen WC, Lin JG, Jeng LB, Yang RS, Fu WM, Tang CH.
    J Bone Miner Res; 2008 Jun; 23(6):961-70. PubMed ID: 18435575
    [Abstract] [Full Text] [Related]

  • 28. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
    Matsumoto Y, Otsuka F, Takano M, Mukai T, Yamanaka R, Takeda M, Miyoshi T, Inagaki K, Sada KE, Makino H.
    Mol Cell Endocrinol; 2010 Aug 30; 325(1-2):118-27. PubMed ID: 20638987
    [Abstract] [Full Text] [Related]

  • 29. Calcium signaling pathway involving calcineurin regulates interleukin-8 gene expression through activation of NF-kappaB in human osteoblast-like cells.
    Mitsuyama H, Kambe F, Murakami R, Cao X, Ishiguro N, Seo H.
    J Bone Miner Res; 2004 Apr 30; 19(4):671-9. PubMed ID: 15005855
    [Abstract] [Full Text] [Related]

  • 30. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB, Fong YC, Tsai HY, Chen YF, Tsuzuki M, Tang CH.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):333-41. PubMed ID: 18495116
    [Abstract] [Full Text] [Related]

  • 31. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M, Otsuka F, Matsumoto Y, Inagaki K, Takeda M, Nakamura E, Tsukamoto N, Miyoshi T, Sada KE, Makino H.
    Mol Cell Endocrinol; 2012 Jan 02; 348(1):224-32. PubMed ID: 21888945
    [Abstract] [Full Text] [Related]

  • 32. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
    Hirata S, Kitamura C, Fukushima H, Nakamichi I, Abiko Y, Terashita M, Jimi E.
    J Cell Biochem; 2010 Dec 15; 111(6):1445-52. PubMed ID: 20830741
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y, Otsuka F, Hino J, Miyoshi T, Takano M, Miyazato M, Makino H, Kangawa K.
    Mol Cell Endocrinol; 2012 Mar 05; 350(1):78-86. PubMed ID: 22155034
    [Abstract] [Full Text] [Related]

  • 35. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM.
    Bone; 2007 Feb 05; 40(2):305-15. PubMed ID: 17049328
    [Abstract] [Full Text] [Related]

  • 36. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J, Osses N, Brandan E.
    J Cell Physiol; 2006 Jan 05; 206(1):58-67. PubMed ID: 15920756
    [Abstract] [Full Text] [Related]

  • 37. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C, Steer JH, Joyce DA, Yip KH, Zheng MH, Xu J.
    J Bone Miner Res; 2003 Dec 05; 18(12):2159-68. PubMed ID: 14672351
    [Abstract] [Full Text] [Related]

  • 38. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells.
    Lee SS, Sharma AR, Choi BS, Jung JS, Chang JD, Park S, Salvati EA, Purdue EP, Song DK, Nam JS.
    Biomaterials; 2012 Jun 05; 33(17):4251-63. PubMed ID: 22436801
    [Abstract] [Full Text] [Related]

  • 39. Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass.
    Nakanishi R, Akiyama H, Kimura H, Otsuki B, Shimizu M, Tsuboyama T, Nakamura T.
    J Bone Miner Res; 2008 Feb 05; 23(2):271-7. PubMed ID: 17907918
    [Abstract] [Full Text] [Related]

  • 40. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
    Washio-Oikawa K, Nakamura T, Usui M, Yoneda M, Ezura Y, Ishikawa I, Nakashima K, Noda T, Yamamoto T, Noda M.
    J Bone Miner Res; 2007 Aug 05; 22(8):1217-23. PubMed ID: 17451368
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.